Korro Bio, Inc. (KRRO) Balance Sheet
As of 2026-06-30 (10-Q), Korro Bio, Inc. (KRRO) reported total assets of $163.4M, total liabilities of $60.2M and shareholders' equity of $103.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $24.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
KRROKorro Bio, Inc.Follow KRRO — free
—
Price chart with a free account
- Market cap
- 176.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 200.2 | 220.3 | 79.6 | 36.3 | 166.2 | 55.6 | 21.8 | 24.9 | |
| Short-term investments | 17.2 | — | 51.1 | 31.1 | 0.0 | 70.5 | 53.3 | 90.1 | |
| Receivables | — | — | — | — | 0.0 | 1.7 | 1.0 | 0.0 | |
| Current assets | 221.4 | 225.1 | 134.7 | 57.1 | 172.7 | 131.5 | 82.4 | 120.6 | |
| Total assets | 223.2 | 264.7 | 185.4 | 73.7 | 221.7 | 226.2 | 113.5 | 163.4 | |
| Current liabilities | 52.8 | 26.6 | 11.4 | 8.7 | 19.5 | 15.0 | 11.9 | 12.6 | |
| Long-term debt | 0.2 | — | — | — | — | — | — | — | |
| Short-term debt | — | — | 0.8 | 10.0 | — | — | — | — | |
| Total liabilities | 55.9 | 72.2 | 54.5 | 8.9 | 51.8 | 65.8 | 62.1 | 60.2 | |
| Shareholders' equity | 167.4 | 192.5 | -42.2 | -99.0 | 169.9 | 160.4 | 51.4 | 103.2 |
USD millions · SEC XBRL
Korro Bio, Inc. — questions
- How much cash does Korro Bio, Inc. have?
- $24.9M in cash and cash equivalents as of 2026-06-30.
- What are Korro Bio, Inc.'s total assets?
- $163.4M as of 2026-06-30.
- What is Korro Bio, Inc.'s shareholders' equity?
- $103.2M as of 2026-06-30.
Every figure on this page comes from Korro Bio, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.